Today's internet news cycle reports that Abbott has received a "CE" mark for the third generation of its product: the Freestyle Libre 3. The news reports suggest the Libre 3 is a continuous glucose monitor that will send data every minute via software to a mobile phone.
The news reports indicate the Freestyle Libre 3 will be rolled out throughout Europe in the coming months.
The news articles also hint that the Freestyle Libre 3 will be priced similarly to the first generation Freestyle Libre.
United Kingdom users of Abbott's first generation Freestyle Libre were told the same thing about the Freestyle Libre 2 which is still unavailable in the UK almost 2 years later.
Will United Kingdom users be able to use the Freestyle Libre 2 and the Freestyle Libre 3 ever?
If so when?
Are we going to have to wait until 2022 at the earliest before being given access to the Freestyle Libre 3?
Covid 19 notwithstanding, why is UK availability of the new iterations of the Freestyle Libre taking so long?
Are the MHRA or NHS holding up the release of these products? If so, why?
The news reports indicate the Freestyle Libre 3 will be rolled out throughout Europe in the coming months.
The news articles also hint that the Freestyle Libre 3 will be priced similarly to the first generation Freestyle Libre.
United Kingdom users of Abbott's first generation Freestyle Libre were told the same thing about the Freestyle Libre 2 which is still unavailable in the UK almost 2 years later.
Will United Kingdom users be able to use the Freestyle Libre 2 and the Freestyle Libre 3 ever?
If so when?
Are we going to have to wait until 2022 at the earliest before being given access to the Freestyle Libre 3?
Covid 19 notwithstanding, why is UK availability of the new iterations of the Freestyle Libre taking so long?
Are the MHRA or NHS holding up the release of these products? If so, why?